Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)

  1. Constanza Salinas-Rebolledo
  2. Javier Blesa
  3. Guillermo Valenzuela-Nieto
  4. David Schwefel
  5. Natalia López González del Rey
  6. Maxs Méndez-Ruette
  7. Janine Burkhalter
  8. Elizabeth Carrazana
  9. Francisca Díaz-Tejeda
  10. Ignacio Arias Catalán
  11. Claudio Cappelli Leon
  12. Natalia Salvadores
  13. Luis Federico Bátiz
  14. Ronald Jara
  15. José A Obeso
  16. Pedro Chana-Cuevas
  17. Gopal P Sapkota
  18. Alejandro Rojas-Fernandez  Is a corresponding author
  1. Austral University of Chile, Chile
  2. HM Hospitales, Spain
  3. Universidad San Sebastian, Chile
  4. Technische Universität Berlin, Germany
  5. Universidad de Los Andes, Chile
  6. Universidad Mayor, Chile
  7. Universidad de Santiago de Chile, Chile
  8. University of Dundee, United Kingdom

Abstract

The p97 protein is a member of the AAA + family of ATPases. This protein is encoded by the VCP gene. It is a mechanoenzyme that uses energy from ATP hydrolysis to promote protein unfolding and segregation actively. The unfolded products are subsequently presented to the 26S proteasome for degradation. p97 substrate recognition is mediated by adaptors, which interact with substrates directly or indirectly through ubiquitin modifications, resulting in substrate funnelling into the central pore of the p97 hexamer and unfolding. Here, we engineered synthetic adaptors to target specific substrates to p97, using the extraordinary intracellular binding capabilities of camelid nanobodies fused to the UBX domain of the p97 adaptor protein Fas-associated factor-1 (FAF1). In such a way, we created a p97-directed proteolysis-targeting chimera (PROTAC), representing a novel and unique E3 ubiquitin ligase-independent strategy to promote specific proteolysis. All functional assays were performed in human cell lines to evaluate the system's efficacy and specificity in a physiologically relevant context.

Data availability

All data generated in this study are included in the manuscript and supporting files. Source data files for all gels and blots are provided for each main and supplementary figure, including original unprocessed images and labeled versions.

Article and author information

Author details

  1. Constanza Salinas-Rebolledo

    Faculty of Medicine, Austral University of Chile, Valdivia, Chile
    Competing interests
    Constanza Salinas-Rebolledo, Is an investor of the patent request WO2023187761A1.
  2. Javier Blesa

    Comprehensive Neuroscience Center AC (CINAC), HM Hospitales, Madrid, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4257-1325
  3. Guillermo Valenzuela-Nieto

    Health Care Science Faculty, Universidad San Sebastian, Valdivia, Chile
    Competing interests
    No competing interests declared.
  4. David Schwefel

    Chair of Bioanalytics, Technische Universität Berlin, Berlin, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2945-0908
  5. Natalia López González del Rey

    Comprehensive Neuroscience Center AC (CINAC), HM Hospitales, Madrid, Spain
    Competing interests
    No competing interests declared.
  6. Maxs Méndez-Ruette

    Facultad de Medicina, Universidad de Los Andes, Santiago, Chile
    Competing interests
    No competing interests declared.
  7. Janine Burkhalter

    Faculty of Medicine, Austral University of Chile, Valdivia, Chile
    Competing interests
    No competing interests declared.
  8. Elizabeth Carrazana

    Center for Biomedicine, Universidad Mayor, Temuco, Chile
    Competing interests
    No competing interests declared.
  9. Francisca Díaz-Tejeda

    Faculty of Medicine, Austral University of Chile, Valdivia, Chile
    Competing interests
    No competing interests declared.
  10. Ignacio Arias Catalán

    Faculty of Sciences, Austral University of Chile, Valdivia, Chile
    Competing interests
    No competing interests declared.
  11. Claudio Cappelli Leon

    Faculty of Sciences, Austral University of Chile, Valdivia, Chile
    Competing interests
    No competing interests declared.
  12. Natalia Salvadores

    Center for Biomedicine, Universidad Mayor, Temuco, Chile
    Competing interests
    No competing interests declared.
  13. Luis Federico Bátiz

    Facultad de Medicina, Universidad de Los Andes, Santiago, Chile
    Competing interests
    No competing interests declared.
  14. Ronald Jara

    Faculty of Medicine, Austral University of Chile, Valdivia, Chile
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0009-0005-2861-3911
  15. José A Obeso

    Comprehensive Neuroscience Center AC (CINAC), HM Hospitales, Madrid, Spain
    Competing interests
    No competing interests declared.
  16. Pedro Chana-Cuevas

    Faculty of Medical Science, Universidad de Santiago de Chile, Chile, Chile
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9946-3299
  17. Gopal P Sapkota

    MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9931-3338
  18. Alejandro Rojas-Fernandez

    Faculty of Medicine, Austral University of Chile, Valdivia, Chile
    For correspondence
    alejandro.rojas@uach.cl
    Competing interests
    Alejandro Rojas-Fernandez, Is an investor of the patent request WO2023187761A1.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6004-5425

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico (1200427)

  • Alejandro Rojas-Fernandez

Fondo Nacional de Desarrollo Científico y Tecnológico (3220635)

  • Guillermo Valenzuela-Nieto

Fondo Nacional de Desarrollo Científico y Tecnológico (13220075)

  • Guillermo Valenzuela-Nieto
  • Alejandro Rojas-Fernandez

Agencia Nacional de Investigación y Desarrollo (21170632)

  • Constanza Salinas-Rebolledo

Centro Ciencia & Vida, FB210008, Financiamiento Basal para Centros Científicos y Tecnológicos de Excelencia de ANID (FB210008)

  • Alejandro Rojas-Fernandez

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2025, Salinas-Rebolledo et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Constanza Salinas-Rebolledo
  2. Javier Blesa
  3. Guillermo Valenzuela-Nieto
  4. David Schwefel
  5. Natalia López González del Rey
  6. Maxs Méndez-Ruette
  7. Janine Burkhalter
  8. Elizabeth Carrazana
  9. Francisca Díaz-Tejeda
  10. Ignacio Arias Catalán
  11. Claudio Cappelli Leon
  12. Natalia Salvadores
  13. Luis Federico Bátiz
  14. Ronald Jara
  15. José A Obeso
  16. Pedro Chana-Cuevas
  17. Gopal P Sapkota
  18. Alejandro Rojas-Fernandez
(2025)
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)
eLife 14:e101496.
https://doi.org/10.7554/eLife.101496

Share this article

https://doi.org/10.7554/eLife.101496